Skip to main content
Log in

Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats

  • Organ Toxicity and Mechanisms
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The experimental anticancer drug cyclopentenyl cytosine (CPEC) was associated with cardiotoxicity in a phase I study. The aim of the present study was twofold; first we investigated whether the observed effects could be reproduced in in-vitro and in-vivo rat models. Second, we intended to investigate the underlying mechanism of the possible cardiotoxicity of CPEC. Effects on frequency and contractility were studied on the isolated atria of 18 male Wistar rats. Atria were incubated with 0.1 mmol L−1 (n=6) or 1 mmol L−1 (n=6) CPEC for 1.5 h and compared with control atria (incubation with buffer solution, n=6). The cardiac apoptosis-inducing potential was studied in-vivo on 66 rats by 99mTc-Annexin V scintigraphy, followed by postmortem determination of radioactivity in tissues, histological confirmation with the TUNEL assay (late-phase apoptosis), and immunohistochemical staining for cleaved caspase 3 and cytochrome C (early-phase apoptosis). Serum levels of the necrotic cardiomyopathy marker troponin T were also determined. No effect on heart frequency was found in the isolated atria after CPEC treatment. A trend towards a decrease of contraction force was observed. However, the differences were not statistically significant. 99mTc-Annexin V scintigraphy showed no increase in cardiac uptake ratio upon CPEC treatment in the in-vivo rat model, which was confirmed by determination of radioactivity in heart versus blood ratios. At each section a few individual isolated late apoptotic cells (<5) could be identified by the TUNEL assay in the highest CPEC dose group (90 mg kg−1) but not in controls or in rats treated with 60 mg kg−1 CPEC. Staining for the early apoptosis markers cleaved caspase 3 and cytochrome C did not reveal any significant differences between treated and control rats. Cardiac troponin T levels were not increased after CPEC treatment. CPEC does not affect heart frequency or contraction force in our cardiotoxicity models. Moreover, we did not find an indication of CPEC-induced apoptosis in heart tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 31:2022–2028

    Google Scholar 

  • Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki L (2000) Acute doxorubicin cardiotoxicity involves cardiomyocite apoptosis. Cancer Res 60:1789–1792

    CAS  PubMed  Google Scholar 

  • Bennink RJ, Hoff MJ van den, Hemert FJ van, Bruin KM de, Spijkerboer AL, Vanderheyden JL, Steinmetz N, Eck-Smit BL van (2004) Annexin-V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J Nucl Med 45:842–848

    Google Scholar 

  • Blaney SM, Balis FM, Grem J, Cole DE, Adamson PC, Poplack DG (1992) Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res 52:3503–3505

    Google Scholar 

  • Blankenberg FG, Strauss HW (1999b) Non-invasive diagnosis of acute heart- or lung-transplantation rejection using radiolabeled annexin V. Pediatr Radiol 29:299–305

    Google Scholar 

  • Blankenberg FG, Katsikis PD, Tait JF Davis E, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95:6349–6354

    Article  Google Scholar 

  • Blankenberg FG, Katsikis PD, Tait JF, Davis E, Naumovski L, Ohtsuki K, Kopiwoda S, Abram MJ, Strauss HW (1999a). Imaging of apoptosis (programmed cell death) with 99mTc Annexin V. J Nucl Med 40:184–191

    Google Scholar 

  • Chandrashekhar Y, Narula J (2003) Death hath a thousand doors to let out life. Circ Res 92:710–714

    Article  Google Scholar 

  • Ford H, Cooney DA, Ahluwalia GS, Hao Z, Rommel ME, Hicks L, Dobyns KA, Tomaszewski JE, Johns DG (1991) Cellular pharmacology of cyclopentenyl cytosine in molt-4 lymphoblasts. Cancer Res 51:3733–3740

    Google Scholar 

  • Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501

    Article  CAS  PubMed  Google Scholar 

  • Guchelaar HJ, Vermes A, Vermes I, Haanen C (1997) Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci 19:119–125

    Article  Google Scholar 

  • Guchelaar HJ, Vermes I, Koopmans RP, Reutelingperger CH (1998) Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 42:77–83

    Article  Google Scholar 

  • Habraken JBA, Bruin KM de, Shehata M, Booij J, Bennink RJ, Eck-Smit BLF van, Busemann-Sokole E (2001) Evaluation of high-resolution pinhole SPECT using a small rotating animal. J Nucl Med 42:1863–1869

    CAS  PubMed  Google Scholar 

  • Heerde WL van, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA, Smits JFM, Daemen MJAP, Reutelingsperger CPM (2000) Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiov Res 45:549–559

    Article  Google Scholar 

  • Kostin S, Pool L, Elsässer A, Hein S, Drexler HCA, Arnon E, Hayakawa Y, Zimmermann R, Bauer E, Klövekorn WP, Schaper J (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92:715–724

    Article  Google Scholar 

  • Kotamraju S, Konorev EA, Joseph J, Kalylanaraman (2000) Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. J Biol Chem 43:33585–33592

    Article  Google Scholar 

  • Meinardi MT, Gietema JA, Veldhuisen DJ van, Graaf WT van der, Vries EGE, Sleijfer DT (2000) Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 26:429–447

    Article  Google Scholar 

  • O’Brien PJ, Dameron GW, Beck ML, Kang YJ, Erickson BK, Battista THD, Miller KE, Jackson KN, Mittelstadt S (1997) Cardiac Troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sc 47:486–495

    CAS  PubMed  Google Scholar 

  • Ohtsuki K, Akashi K, Aoka Y, Blankenberg FG, Kopiwoda S, Tait J, Strauss W (1999) Technetium-99 m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med 26:1251–1258

    Article  Google Scholar 

  • Politi PM, Xie F, Dahut W, Ford H, Kelley JA, Bastian A, Setser A, Allegra CJ, Chen AP, Hamilton JM, Arbuck SF, Linz P, Brammer H, Grem JL (1995) Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemother Pharmacol 36:513–523

    Google Scholar 

  • Sawyer DB, Fukazawa R, Arstall MA, Kelly RA (1999) Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res 84:257–265

    Google Scholar 

  • Schimmel KJM, Richel DJ, Brink RBA van den, Guchelaar HJ (2004) Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30:181–191

    Article  Google Scholar 

  • Sternberger LA, Sternberger NH (1986) The unlabeled antibody method. Comparison of peroxidase–antiperoxidase with avidin–biotin complex by a new method of quantification. J Histochem Cytochem 34:599–605

    Google Scholar 

  • Tait JF, Smith C (1991) Site-specific mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipid binding. Arch Biochem Biophys 288:141–144

    Article  Google Scholar 

  • Verschuur AC, Gennip AH van, Leen R, Meinsma R, Voûte PA, Kuilenburg ABP (2000) In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia. Br J Haematol 110:161–169

    Article  Google Scholar 

  • Verschuur AC, Brinkman J, Gennip AH van, Leen R, Vet R, Evers L, Voute PA, Kuilenburg ABP (2001) Cyclopentenyl cytosine induces apoptosis and increases cytarabine induced apoptosis in a T-Lymphoblastic leukemic cell-line. Leuk Res 25:891–900

    Article  Google Scholar 

  • Viaro F, Dalio MB, Evora PRB (2002) Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated. Chest 122:1061–1066

    Article  Google Scholar 

Download references

Acknowledgements

Dr M van den Hoff is financially supported by The Netherlands Heart Foundation (grant M96.003). The animal studies were performed after approval of the Ethical Animal Research Committee of the University of Amsterdam and following its guidelines.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kirsten Schimmel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schimmel, K., Bennink, R., de Bruin, K. et al. Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats. Arch Toxicol 79, 268–276 (2005). https://doi.org/10.1007/s00204-004-0633-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-004-0633-5

Keywords

Navigation